The Hoon Research Laboratory, led by Mrinalini Hoon, PhD, assistant professor, has been awarded $500,000 by the UW2020: WARF Discovery Initiative Cohort for the project, “Imaging the Third Dimension at the Nanometer Resolution.” The award …
research
Can precision medicine treat childhood blindness?
Using stem cells, gene therapy to correct errors in retinal cells A research team at the University of Wisconsin School of Medicine and Public Health has shown that two novel approaches to treating an inherited …
Early Detection Critical to Treating Glaucoma
[KGVID]https://www.ophth.wisc.edu/wp-content/uploads/2019/01/Glaucoma-Jan-2019-.mp4[/KGVID] Glaucoma is a major cause of vision loss worldwide. It affects more than 3 million people in the United States—nearly half of whom are unaware they have the disease. During Glaucoma Awareness Month …
Lions Eye Bank of Wisconsin Gift of Sight Discovery Award is Announced
Yao Liu, MD, and Stuart Tompson, PhD, received this year’s Lions Eye Bank of Wisconsin (LEBW) Gift of Sight Discovery Award through an internal competition open to UW Department of Ophthalmology and Visual Sciences (DOVS) …
Research to Prevent Blindness Awards Department with Unrestricted Grant
The University of Wisconsin-Madison School of Medicine and Public Health has been granted an Unrestricted Grant by Research to Prevent Blindness (RPB) in the amount of $115,000 a year to support eye research conducted by …
Art, In Spite of AMD
Jefferey Lange is fascinated by the beauty and arrangement of colors and textures. As an artist diagnosed with age-related macular degeneration (AMD), Lange is acutely aware of being able to see colors and textures. Lange …
Improving Glaucoma Treatment // Experimental Gene Transfer Techniques
Listen to Full Interview In an interview with WYPL-FM’s (Memphis, TN) radio show Eye on Vision, Curtis Brandt, PhD, professor of ophthalmology and visual sciences, discussed the research of experimental gene transfer techniques to …
AREDS2
Age-Related Eye Disease Study 2 (AREDS2) 10-Year Follow-On Study
Zoster Eye Disease Study (ZEDS)
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Suppressive Valacyclovir for One Year in Immunocompetent Study Participants with an Episode of Dendriform Epithelial Keratitis, Stromal Keratitis, Endothelial Keratitis, and/or Iritis Due to Herpes Zoster Ophthalmicus (HZO) in the Year Prior to Enrollment (ZEDS)